 Norges Bank purchased a new position in Aimmune Therapeutics Inc NASDAQ:AIMT during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission SEC. The firm purchased 493,939 shares of the biotechnology companys stock, valued at approximately 16,532,000. Norges Bank owned 0.79 of Aimmune Therapeutics as of ... 